Literature DB >> 10086777

Protein disulphide isomerase mediates platelet aggregation and secretion.

D W Essex1, M Li.   

Abstract

Platelet surface thiols and disulphides play an important role in platelet responses. Agents that reduce disulphide bonds expose the fibrinogen receptor in platelets and activate the purified glycoprotein (GP) IIbIIIa receptor. Protein disulphide isomerase (PDI), an enzyme that rearranges disulphides bonds, is found on the platelet surface where it is catalytically active. We investigated the role of PDI in platelet responses using (1) rabbit anti-PDI IgG specific for PDI, (2) a competing substrate (scrambled ribonuclease A), and (3) the PDI inhibitor, bacitracin. Fab fragments of the rabbit anti-PDI IgG inhibited platelet responses to the agonists tested (ADP and collagen), whereas Fab fragments prepared identically from normal rabbit IgG had no inhibitory effect. Scrambled ribonuclease A blocked platelet aggregation and secretion, but native ribonuclease A did not. When biphasic platelet aggregation was examined using platelets in citrated plasma, the principle effect of bacitracin was on second phase or irreversible aggregation responses and the accompanying secretion. Using flow cytometry and an antibody specific for activated GPIIbIIIa (PAC-1), the rabbit anti-PDI Fab fragments substantially inhibited activation of GPIIbIIIa when added before, but not after, platelet activation. In summary, we have demonstrated that protein disulphide isomerase mediates platelet aggregation and secretion, and that it activates GPIIbIIIa, suggesting this receptor as the target of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086777     DOI: 10.1046/j.1365-2141.1999.01197.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  38 in total

1.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Authors:  Gunjan Malik; Lynn M Knowles; Rajiv Dhir; Shuping Xu; Shuting Yang; Erkki Ruoslahti; Jan Pilch
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  The disulfide isomerase ERp57 is required for fibrin deposition in vivo.

Authors:  J Zhou; Y Wu; L Wang; L Rauova; V M Hayes; M Poncz; D W Essex
Journal:  J Thromb Haemost       Date:  2014-09-26       Impact factor: 5.824

Review 3.  Vascular thiol isomerases.

Authors:  Robert Flaumenhaft; Bruce Furie
Journal:  Blood       Date:  2016-06-29       Impact factor: 22.113

Review 4.  Protein disulfide isomerase in thrombosis and vascular inflammation.

Authors:  J Cho
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

5.  The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis.

Authors:  Yi Wu; Syed S Ahmad; Junsong Zhou; Lu Wang; Matthew P Cully; David W Essex
Journal:  Blood       Date:  2011-12-29       Impact factor: 22.113

Review 6.  Protein disulfide isomerase as an antithrombotic target.

Authors:  Robert Flaumenhaft
Journal:  Trends Cardiovasc Med       Date:  2013-03-27       Impact factor: 6.677

7.  A new antithrombotic strategy: inhibition of the C-terminal active site of protein disulfide isomerase.

Authors:  L Wang; D W Essex
Journal:  J Thromb Haemost       Date:  2017-02-28       Impact factor: 5.824

8.  Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase.

Authors:  N Ramachandran; P Root; X M Jiang; P J Hogg; B Mutus
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

9.  Probing for thiol isomerase activity in thrombi.

Authors:  R Flaumenhaft
Journal:  J Thromb Haemost       Date:  2016-03-07       Impact factor: 5.824

Review 10.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.